Hjem › Diffus sclerodermi › Michigan
Diffus sclerodermi kliniske forsøg i Michigan
7 studier for Diffus sclerodermi søger deltagere på steder i Michigan.
Byer i Michigan
Officiel studietekst (engelsk)
A Clinical Study to Evaluate Ianalumab in Participants With Diffuse Cutaneous Systemic Sclerosis
- Uni Of Michigan Health System, Ann Arbor
- Wayne State University, Detroit
- Clinical Research Inst of MI, Saint Clair Shores
RekruttererFase 2
Alder 18 til 70 · Alle køn · Opdateret 28. sep. 2026 · NCT06470048A Study of the Efficacy and Safety of Belimumab in Adults With Systemic Sclerosis Associated Interstitial Lung Disease
- GSK Investigational Site, Ann Arbor
RekruttererFase 2/3
Alder 18 og opefter · Alle køn · Opdateret 8. sep. 2026 · NCT05878717Platform Clinical Study for Conquering Scleroderma
- University of Michigan, Ann Arbor
RekruttererFase 2
Alder 18 og opefter · Alle køn · Opdateret 18. aug. 2026 · NCT06195072RESET-SSc: An Open-Label Study to Evaluate the Safety and Efficacy of CABA-201, a CD19-CAR T Cell Therapy, in Subjects With Systemic Sclerosis
- University of Michigan, Ann Arbor
RekruttererFase 2/3
Alder 18 til 75 · Alle køn · Opdateret 17. aug. 2026 · NCT06328777A Phase 1/2 Study of NKX019 in Subjects With Immune-Mediated Diseases (Ntrust-2)
- Nkarta Investigational Site, Ann Arbor
RekruttererFase 1/2
Alder 18 til 75 · Alle køn · Opdateret 7. aug. 2026 · NCT06733935A Study of Nemolizumab for the Treatment of Adults With Systemic Sclerosis
- Galderma Investigational Site # 8743, Ann Arbor
RekruttererFase 2
Alder 18 og opefter · Alle køn · Opdateret 31. mar. 2026 · NCT07047690The Apollo Device in Systemic Sclerosis for the Management of fatiguE, Raynaud Phenomenon and qualiTy of Life
- University of Michigan, Ann Arbor
Rekrutterer
Alder 18 og opefter · Alle køn · Opdateret 8. jan. 2026 · NCT06675344Fra ClinicalTrials.gov, data hentet 3. okt. 2026. Hver studie har sine egne kvalifikationskrav; studieteamet afgør, hvem der kan deltage.